HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 90,594 shares at $11.28 ($993K) on 2017-04-06, disclosed to the SEC on 2017-04-10.
Open-market sale of $993k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 24,600 | $276K | 27.8% |
| 2 | $11.28 | 6,617 | $75K | 7.5% |
| 3 | $10.96 | 18,001 | $197K | 19.9% |
| 4 | $11.04 | 3,500 | $39K | 3.9% |
| 5 | $10.73 | 37,876 | $406K | 41.0% |
| Total | $10.96 avg | 90,594 |
| $993K |
| 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |